A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A LONG-TERM EXTENSION STUDY TO EVALUATE THE SAFETY AND EFFICACY OF APG777 IN PATIENTS WITH ATOPIC DERMATITIS PREVIOUSLY TREATED WITH APG777

Intervention/treatment:
APG777
Medical condition:
ATOPIC DERMATITIS
Protocol code:
APG777-202
Control number:
295289
Status:
Recruiting
Approved:
March 12, 2025
Trial phase:
Phase 2
For more information:
ClinicalTrials.gov - NCT07003425
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Study Director
Role
CONTACT
Phone:
7812082408
Sponsor
APOGEE THERAPEUTICS, INC

Locations

Alberta

Investigational Site
Calgary, Alberta, T2J 7E1
RECRUITING
Investigational Site
Calgary, Alberta, T3E 0B2
RECRUITING
Investigational Site
Edmonton, Alberta, T5J 3S9
RECRUITING

British Columbia

Investigational Site
Vancouver, British Columbia, V5Z 4E8
RECRUITING

New Brunswick

Investigational Site
Fredericton, New Brunswick, E3B 1G9
RECRUITING

Ontario

Investigational Site
Ajax, Ontario, L1S 7K8
RECRUITING
Investigational Site
Markham, Ontario, L3P 1X3
RECRUITING
Investigational Site
Mississauga, Ontario, L4Y 4C5
RECRUITING
Investigational Site
Ottawa, Ontario, K1K 4L2
RECRUITING
Investigational Site
Peterborough, Ontario, K9J 5K2
RECRUITING
Investigational Site
Toronto, Ontario, M3B 0A7
RECRUITING
Investigational Site
Toronto, Ontario, M4E 2Y9
RECRUITING
Investigational Site
Toronto, Ontario, M4W 2N4
RECRUITING

Quebec

Investigational Site
Montreal, Quebec, H2X 2V1
RECRUITING
Investigational Site
Québec, Quebec, G1V 4X7
RECRUITING
Did you find what you were looking for?